Literature DB >> 10834305

Thioperamide, a selective histamine H3 receptor antagonist, protects against PTZ-induced seizures in mice.

D Vohora1, S N Pal, K K Pillai.   

Abstract

The effect of selective histamine H3-receptor antagonist thioperamide was studied on PTZ-induced seizures in mice. Thioperamide significantly protected clonic seizures induced by PTZ in a dose-dependent manner. The effect of thioperamide was completely countered by pretreatment with R (alpha)-methylhistamine (RAMH), a selective H3-receptor agonist suggesting that the observed effect of thioperamide was elicited by histamine H3-receptors. RAMH alone did not significantly modify PTZ seizures. The findings are consistent with a role for the histaminergic neuronal system in seizures and suggest that H3-receptors may play an important role in modulating clonic seizures induced by PTZ in mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834305     DOI: 10.1016/s0024-3205(00)00548-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

Review 1.  Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.

Authors:  M Bhowmik; R Khanam; D Vohora
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  Cytoprotective effects of diallyl trisulfide against valproate-induced hepatotoxicity: new anticonvulsant strategy.

Authors:  Ahmed A Shaaban; Dina S El-Agamy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-23       Impact factor: 3.000

3.  Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine H1 receptor activation-linked mechanism.

Authors:  Ashish K Rehni; Thakur Gurjeet Singh; Nirmal Singh; Sandeep Arora
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-10       Impact factor: 3.000

4.  Influence of the novel histamine H₃ receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in mice.

Authors:  Amine Bahi; Bassem Sadek; Stephan J Schwed; Miriam Walter; Holger Stark
Journal:  Psychopharmacology (Berl)       Date:  2013-03-09       Impact factor: 4.530

5.  Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists.

Authors:  Bassem Sadek; Ali Saad; Johannes Stephan Schwed; Lilia Weizel; Miriam Walter; Holger Stark
Journal:  Drug Des Devel Ther       Date:  2016-11-07       Impact factor: 4.162

6.  The Neuroprotective Effects of Histamine H3 Receptor Antagonist E177 on Pilocarpine-Induced Status Epilepticus in Rats.

Authors:  Alaa Alachkar; Sheikh Azimullah; Shreesh K Ojha; Rami Beiram; Dorota Łażewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Molecules       Date:  2019-11-14       Impact factor: 4.411

7.  Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H3 receptor antagonists/inverse agonists containing triazole moiety.

Authors:  Mingxia Song; Rui Yan; Yanhui Zhang; Dongfu Guo; Naiming Zhou; XianQing Deng
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

8.  Experimental study of neuropharmacological profile of Euphorbia pulcherrima in mice and rats.

Authors:  Kundan Kr Singh; Gajendra P Rauniar; Himal Sangraula
Journal:  J Neurosci Rural Pract       Date:  2012-09

9.  Anti-seizure activity of flower extracts of Nepeta bractaeta in Swiss albino mice.

Authors:  Jalal Uddin Bhat; Shabir Ahmad Parray; Mohammad Aslam; Shahid Ansari; Qudsia Nizami; Razia Khanam; Aisha Siddiqui; Mohd Aftab Ahmad
Journal:  EXCLI J       Date:  2012-08-27       Impact factor: 4.068

10.  Studies on Anticonvulsant Effects of Novel Histamine H3R Antagonists in Electrically and Chemically Induced Seizures in Rats.

Authors:  Alaa Alachkar; Dorota Łażewska; Gniewomir Latacz; Annika Frank; Agata Siwek; Annamaria Lubelska; Ewelina Honkisz-Orzechowska; Jadwiga Handzlik; Holger Stark; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Int J Mol Sci       Date:  2018-10-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.